Envista Holdings Corporation (NVST) Analyst/Investor Day September 17, 2026 9:00 AM EDT
Company Participants
Jim Gustafson – Vice President of Investor Relations
Paul Keel – President, CEO & Chairman
Stefan Nilsson – President of Nobel Biocare
Veronica Acurio – Senior VP & President of Orthodontics
Filippo Impieri – President of Consumables
Robert Befidi – Senior VP & President of Diagnostics
Eric Hammes – Senior VP & CFO
Conference Call Participants
Elizabeth Anderson – Evercore ISI Institutional Equities, Research Division
Steven Valiquette – Mizuho Securities USA LLC, Research Division
Jeffrey Johnson – Robert W. Baird & Co. Incorporated, Research Division
Jonathan Block – Stifel, Nicolaus & Company, Incorporated, Research Division
Michael Cherny – Leerink Partners LLC, Research Division
Jason Bednar – Piper Sandler & Co., Research Division
Brandon Vazquez – William Blair & Company L.L.C., Research Division
Kevin Caliendo – UBS Investment Bank, Research Division
Lilia-Celine Lozada – JPMorgan Chase & Co, Research Division
Allen Lutz – BofA Securities, Research Division
Presentation
Jim Gustafson
Vice President of Investor Relations
Good morning, everyone. I’m Jim Gustafson, Vice President of Investor Relations for Envista, and it’s my pleasure to welcome you to our 2026 Investor Day. We want to thank you for your interest in our company. And a special thanks to those of you who’ve made the journey to join us in-person here at our Nobel Biocare facility in Mahwah, New Jersey.
I’d like to remind you that during the presentation, that we are sharing today, it will also be available for download at the Events & Presentations section of our IR website at investors.envistaco.com. Additionally, this is being webcast live on the same Events and Presentations section of our IR website and will be available for replay later today after the event has concluded.
So in our presentation today, we will make forward-looking statements within the meaning of the federal securities laws. These statements are subject to